Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

Clinical trial NCT06624436 · RECRUITING

Trial details

NCT number: NCT06624436
Sponsor: Radboud University Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sepsis Neuroinflammatory Response Immunosuppresion Endotoxemia Anakinra Dexamethasone Tocilizumab

Start date: 2024-10-24
Primary completion: 2025-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.